Startups

Bertis

Bertis develops proteomics-based diagnostics and tools for precision medicine. It measures protein biomarkers in blood to support early disease detection, including the MASTOCHECK breast cancer test, and provides PASS mass-spectrometry-based pan-omics analysis services to pharmaceutical, biotechnology and research organizations. Its DEEP platform applies deep learning to protein identification, quality control and interpretation. Through its SURF initiative, Bertis combines experimental surface-protein data with AI to discover and validate cancer cell-surface drug targets for research collaborations and licensing.

Founded 2014

Team

Daehee HwangScientific Advisory Board Member

David BerryScientific Advisory Board Member

Dong-young NohCo-Chief Executive Officer

Hyojung ParkChief Strategy Officer

Hyunseok KangScientific Advisory Board Member

Jin-Young ChoResearcher, Biomarker Research Team

Jong seo KimScientific Advisory Board Member

Jungkap ParkDirector, Machine Learning Team

Mehra GolshanScientific Advisory Board Member

Sang won LeeScientific Advisory Board Member

Sangtae KimChief Scientist, Informatics and AI

Seung-man HanCo-Chief Executive Officer

Sunghyun HuhHead of Bioinformatics Team

Un-beom KangHead of Biomarker Research Institute

Veronique Tan Kiak MienScientific Advisory Board Member

William S. NobleScientific Advisory Board Member

Investments

₩20B2024-02-26	0 participations
$—Unknown date	Samsung Venture Investment Corporation